Literature DB >> 7173302

Does cantharides blister fluid provide access to the peripheral compartment?

M Schäfer-Korting, H C Korting, S Hiemstra, E Mutschler.   

Abstract

The pharmacokinetics of bendroflumethiazide (BFT) was investigated following the oral administration of 10 mg to 3 healthy volunteers. Each subject participated twice in the study. BFT was determined in plasma and cantharides blister fluid from 1/2 to 30 h post administration. Blister fluid was obtained from blisters 10-22 h old. Plasma levels were fitted to a tri-exponential equation and the concentration of the drug in the peripheral compartment was calculated from the microscopic rate constants. In 5 of 6 cases investigated, cantharides blister fluid levels paralleled the concentration of the drug in the peripheral compartment. The mean blister fluid levels exceeded the calculated concentration in Compartment 2 1.46 fold. In one case, the blister fluid level paralleled the plasma level. This subject clearly differed from the others as more than 10 h were required for blister formation in her. The results suggest that following the administration of BFT, cantharides blister fluid behaves as part of the peripheral compartment. The possible value of studying blister fluid levels in pharmacokinetic investigations is discussed.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7173302     DOI: 10.1007/bf00613614

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  13 in total

1.  S35-LABELED BENDROFLUMETHIAZIDE IN HUMAN BEINGS: CLINICAL STUDIES.

Authors:  H R BRETTELL; J G SMITH; J K AIKAWA
Journal:  Arch Intern Med       Date:  1964-03

Review 2.  The pharmacokinetic bases of biological response quantification in toxicology, pharmacology and pharmacodynamics.

Authors:  E R Garrett
Journal:  Prog Drug Res       Date:  1977

3.  Complex formation between macromolecules and drugs. 8. Binding of saccharine, N-methyl saccharine, and the diuretic drugs hydroflumethiazide and bendroflumethiazide to human serum albumin.

Authors:  A Agren; T Bäck
Journal:  Acta Pharm Suec       Date:  1973-06

4.  Lymph flow and protein in the normal male leg during lying, getting up, and walking.

Authors:  W L Olszewski; A Engeset; J Sokolowski
Journal:  Lymphology       Date:  1977-09       Impact factor: 1.286

5.  Determination of 8-methoxypsoralen in suction-blister fluid and serum by liquid chromatography.

Authors:  M J Herfst; P M Edelbroek; F A de Wolff
Journal:  Clin Chem       Date:  1980-12       Impact factor: 8.327

6.  The influence of protein binding upon tissue fluid levels of six beta-lactam antibiotics.

Authors:  R Wise; A P Gillett; B Cadge; S R Durham; S Baker
Journal:  J Infect Dis       Date:  1980-07       Impact factor: 5.226

7.  Suction blister fluid as a model for interstitial fluid in rats.

Authors:  M J Herfst; H van Rees
Journal:  Arch Dermatol Res       Date:  1978-12-01       Impact factor: 3.017

8.  Determination of 8-methoxypsoralen levels in plasma and skin suction blister fluid by a new sensitive fluorodensitometric method.

Authors:  H C Korting; M Schäfer-Korting; E Roser-Maass; E Mutschler
Journal:  Arch Dermatol Res       Date:  1982       Impact factor: 3.017

9.  Penetration of antibiotic into interstitial tissue fluid following parenteral administration of lysine cephalexin.

Authors:  R Cadórniga; S Barrios; J Segura; D J Roberts
Journal:  Arzneimittelforschung       Date:  1979

10.  Serum and subcutaneous chamber fluid dynamics of penicillins after single large parenteral doses.

Authors:  R R Tight; A C White
Journal:  Antimicrob Agents Chemother       Date:  1980-02       Impact factor: 5.191

View more
  9 in total

Review 1.  Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: distribution in tissue.

Authors:  Markus Müller; Amparo dela Peña; Hartmut Derendorf
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

2.  Direct assessment of peripheral pharmacokinetics in humans: comparison between cantharides blister fluid sampling, in vivo microdialysis and saliva sampling.

Authors:  M Brunner; A Schmiedberger; R Schmid; D Jäger; E Piegler; H G Eichler; M Müller
Journal:  Br J Clin Pharmacol       Date:  1998-11       Impact factor: 4.335

Review 3.  Regulation of cortisol bioavailability--effects on hormone measurement and action.

Authors:  Ilias Perogamvros; David W Ray; Peter J Trainer
Journal:  Nat Rev Endocrinol       Date:  2012-08-14       Impact factor: 43.330

4.  Human plasma and skin blister fluid levels of griseofulvin following a single oral dose.

Authors:  M Schäfer-Korting; H C Korting; E Mutschler
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

5.  Penetration of trimethoprim and sulfamethoxazole into skin blister fluid.

Authors:  A Nowak; M Kadyków; A Klimowicz
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

6.  Multiple-dose pharmacokinetics of ofloxacin in serum, saliva, and skin blister fluid of healthy volunteers.

Authors:  R Warlich; H C Korting; M Schäfer-Korting; E Mutschler
Journal:  Antimicrob Agents Chemother       Date:  1990-01       Impact factor: 5.191

7.  Cefodizime in serum and skin blister fluid after single intravenous and intramuscular doses in healthy volunteers.

Authors:  H C Korting; M Schäfer-Korting; L Maass; N Klesel; E Mutschler
Journal:  Antimicrob Agents Chemother       Date:  1987-11       Impact factor: 5.191

8.  Correlations between theophylline concentrations in plasma, erythrocytes and cantharides-induced blister fluid and peak expiratory flow in asthma patients.

Authors:  F Philip-Joet; B Bruguerolle; M Reynaud; A Arnaud
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

9.  Human plasma and skin blister fluid levels of griseofulvin after its repeated administration.

Authors:  M Schäfer-Korting; H C Korting; E Mutschler
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.